Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | PTGX | APGE | ||
| Company | Crispr Therapeutics Ag | Protagonist Therapeutics Inc | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 56.45 | 88.53 | 77.78 | ||
| High | 56.83 | 89.47 | 78.74 | ||
| Low | 55.21 | 87.47 | 76.76 | ||
| Latest | 56.71 | 88.84 | 78.09 | ||
| Change | +0.25 | +0.11 | +0.79 | ||
| % Change | +0.44% | +0.12% | +1.02% | ||
| Volume | 652,900 | 154,000 | 465,100 | ||
| 20-Day Average Volume | 1,715,965 | 1,026,160 | 946,410 | ||
| Previous Close | 56.46 | 88.73 | 77.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.85 | 89.18 | 75.21 | ||
| 20-Day Raw Stochastic | 65.11% | 40.86% | 78.21% | ||
| 20-Day Relative Strength | 49.78 | 55.86 | 69.01 | ||
| Weighted Alpha | +33.92 | +81.15 | +92.22 | ||
| Today's Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.60% since 12/17/25 | -0.56% since 12/17/25 | +3.43% since 12/17/25 | ||
| Low | 54.50 on 12/22/25 | 84.11 on 12/18/25 | 74.54 on 12/18/25 | ||
| High | 59.18 on 12/22/25 | 90.01 on 12/18/25 | 80.99 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +10.65% since 11/24/25 | +1.31% since 11/24/25 | +15.09% since 11/24/25 | ||
| Low | 49.96 on 11/25/25 | 83.52 on 12/02/25 | 67.66 on 11/25/25 | ||
| High | 59.77 on 12/04/25 | 96.54 on 12/15/25 | 80.99 on 12/19/25 | ||
| 3-Month | |||||
| %Chg | -7.11% since 09/24/25 | +34.71% since 09/24/25 | +103.25% since 09/24/25 | ||
| Low | 48.02 on 11/21/25 | 62.24 on 10/07/25 | 36.85 on 09/26/25 | ||
| High | 78.48 on 10/08/25 | 96.54 on 12/15/25 | 80.99 on 12/19/25 | ||
| 6-Month | |||||
| %Chg | +21.23% since 06/24/25 | +65.50% since 06/24/25 | +79.31% since 06/24/25 | ||
| Low | 45.60 on 06/26/25 | 49.38 on 07/08/25 | 34.34 on 08/08/25 | ||
| High | 78.48 on 10/08/25 | 96.54 on 12/15/25 | 80.99 on 12/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,404,463 | 5,553,921 | 5,335,108 | ||
| Shares Outstanding, K | 95,300 | 62,516 | 68,320 | ||
| Annual Sales | 37,310,000 | 434,430,000 | 0 | ||
| Annual Net Income | -366,250,000 | 275,190,000 | -182,150,000 | ||
| Last Quarter Sales | 890,000 | 4,710,000 | 0 | ||
| Last Quarter Net Income | -106,440,000 | -39,340,000 | -65,020,000 | ||
| 60-Month Beta | 1.74 | 2.19 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/10/25 | -0.62 on 11/06/25 | -1.11 on 11/10/25 | ||
| Latest Earnings Date | 02/10/26 | 02/20/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 143.11 | 0.00 | ||